CV Sciences (CVSI) Revenue (QoQ) (2013 - 2026)
CV Sciences (CVSI) Revenue (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.57% |
| Mar 31, 2026 | -3.39% |
| Dec 31, 2025 | 1.57% |
| Sep 30, 2025 | -10.06% |
| Jun 30, 2025 | 0.39% |
| Mar 31, 2025 | -7.16% |
| Dec 31, 2024 | 0.49% |
| Sep 30, 2024 | -2.25% |
| Jun 30, 2024 | -1.20% |
| Mar 31, 2024 | 5.29% |
| Dec 31, 2023 | -7.04% |
| Sep 30, 2023 | 3.10% |
| Jun 30, 2023 | -4.39% |
| Mar 31, 2023 | 7.21% |
| Dec 31, 2022 | 3.15% |
| Sep 30, 2022 | -9.35% |
| Jun 30, 2022 | -6.95% |
| Mar 31, 2022 | -10.51% |
| Dec 31, 2021 | -2.70% |
| Sep 30, 2021 | -0.41% |